Prevention of mortality from hepatitis B and hepatitis C

Lancet. 2006 Sep 9;368(9539):896-7. doi: 10.1016/S0140-6736(06)69347-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Hepatocellular / etiology*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / prevention & control
  • Female
  • Hepatitis B / complications*
  • Hepatitis B / prevention & control
  • Hepatitis B / transmission
  • Hepatitis C, Chronic / complications*
  • Hepatitis C, Chronic / prevention & control
  • Hepatitis C, Chronic / transmission
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control
  • Lamivudine / therapeutic use
  • Liver Cirrhosis / etiology
  • Liver Neoplasms / etiology*
  • Liver Neoplasms / mortality
  • Liver Neoplasms / prevention & control

Substances

  • Lamivudine